Patent Assignment
Reel/Frame 060541/0374
Change of Address
Recorded: 2022-06-28
Pages: 5
Assignor
GALDERMA HOLDING SA
Executed: 2022-02-17
Assignee
GALDERMA HOLDING SA
ZÄHLERWEG 10, ZUG, 6300, SWITZERLAND
Covered Properties
(74)
Compounds, Formulations, and Methods for Treating or Preventing Rosacea
Topical Application of Ivermectin for the Treatment of Dermatological Conditions/Afflictions
Compounds, Formulations, and Methods for Ameliorating Telangiectasias
Dermatological cream-gels containing avermectin compounds
Homogeneously Formulating Microdosed Active Principles
Solubilizing of Metronidazole
Production of Bepromoline
Inverse Emulsions Comprising Avermectins and Cosmetic/Dermatological Applications Thereof
Compositions Comprising at Least One Aqueous Phase and at Least One Fatty Phase Which Comprises Avermectin Compounds
Double compartment skincare products comprising avermectin/milbemycin compounds
Dermatological Compositions Comprising Avermectin Nanocapsules
Administration of Fluocinolone Acetonide, Tretinoin and Hydroquinone Cream in Melasma Maintenance Therapy
Preparation of Amorolfine
Topical Application of Ivermectin for the Treatment of Dermatological Conditions/Afflictions
Topical Application of Ivermectin for the Treatment of Dermatological Conditions/Afflictions
Compounds, Formulations, and Methods for Treating or Preventing Inflammatory Skin Disorders
Production of Bepromoline
Method for Solubilizing Metronidazole
Administration of Avermectin/Milbemycin Compounds for the Treatment of Ophthalmic Pathologies
Topical Application of Ivermectin for the Treatment of Dermatological Conditions/Afflictions
Compositions Comprising Avermectin/Azelaic Acid Compounds Useful for Treating E.G., Rosacea
Topical Application of Ivermectin for the Treatment of Dermatological Conditions/Afflictions
Dermatological Compositions Comprising Avermectin Nanocapsules
Administration of Avermectin/Milbemycin Compounds for the Treatment of Ophthalmic Pathologies
Compositions Comprising at Least One Aqueous Phase and at Least One Fatty Phase Which Comprises Avermectin Compounds
Compounds, Formulations, and Methods for Treating or Preventing Inflammatory Skin Disorders
Compounds, Formulations, and Methods for Treating or Preventing Inflammatory Skin Disorders
Topical Application of Ivermectin for the Treatment of Dermatological Conditions/Afflictions
Compositions Comprising Avermectin/Azelaic Acid Compounds Useful for Treating, E.G., Rosacea
Topical Application of Ivermectin for the Treatment of Dermatological Conditions/Afflictions
Administration of Avermectin/Milbemycin Compounds for the Treatment of Ophthalmic Pathologies
Bpo Wash Gel Composition
Use of a Macrocyclic Lactone for Treating a Complication from a Papilloma Virus Infection
Track-Indexed Syringe
Process for Preparing a Cross-Linked Hyaluronic Acid Product
Modified Release Doxycycline Composition
Prostaglandin F2Alpha and Analogues Thereof for Treating Atrophic Cutaneous Scarring
Single-Step Functionalization and Cross-Linking of Hyaluronic Acid
Injection Device
Method of Reducing Hair Loss Associated with Chemotherapy
Modified Release Doxycycline Composition
Enantiopure or Enantioenriched Bdde and Its Use as Crosslinking Agent in the Manufacture of Cross-Linked Products
Composition Comprising a Compound from the Family of Avermectins and Doxycycline for the Treatment of Rosacea
Compositions Comprising a Compound from the Family of Avermectins and an Agonist Compound for at Least One of the Retinoic Acid Receptors for Treating Acne
Grafting of Cyclodextrin by Amide Bonds to an Ether Cross-Linked Hyaluronic Acid and Uses Thereof
Graft Copolymer
Compound from the Avermectin Family for Treating and/or Preventing Folliculitis
Track-Indexed Syringe
Topical Application of Ivermectin for the Treatment of Dermatological Conditions/Afflictions
Compound of the Avermectin Family or of the Milbemycin Family for the Treatment and/or Prevention of Atopic Dermatitis
A Process for Efficient Cross-Linking of Hyaluronic Acid
A Process for Preparing a Stable Emulsion Comprising One or More Avermectins
A Process for Preparing a Composition Comprising a High Concentration of One or More Avermectins
Use of Ivermectin and Brimonidine in the Treatment and/or Prevention of Moderate to Severe Rosacea
Method of Reducing Hair Loss Associated with Chemotherapy
Modified Release Doxycycline Composition
Topical Wash Composition for Use in Acne Patients
Hydrolysis of Ester Bonds in Amide Crosslinked Glycosaminoglycans
A Syringe
Method for Cleaving Amide Bonds
Method for Preparing Acylated Crosslinked Glycosaminoglycans
Plunger Slack Syringe
Method for Cleaving Amide Bonds
Cyclodextrin-Grafted Cross-Linked Hyaluronic Acid Complexed with Active Drug Substances and Uses Thereof
Compositions and the Use Thereof for Treating or Preventing Rosacea
Hyaluronic Acid Gel with a Divalent Zinc Cation
Modified Release Doxycycline Composition
Micro- or Nanoparticular Vesicles Comprising Crosslinked Hyaluronic Acid, Compositions Comprising the Same and Method for Their Use in Skin Care
Composition Comprising a Crosslinked Hyaluronic Acid (Ha) in Combination with a Low-Molecular Ha and/or an Agent Stimulating Endogenous Ha Synthesis
Composition Comprising Avermectin Compounds Without Gelling Agents
Composition Comprising Avermectin Compounds Without Solid Fatty Substances
Composition Comprising Avermectin Compounds Without Solvents and Propenetrating Agents of Avermectin Compounds
Method for Manufacturing a Shaped Cross-Linked Hyaluronic Acid Product
Needle Tip
Patent:
836,324 →
Application:
29/608,176 →
Related Assignments
(11)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 28, 2013
From: SANSROSA PHARMACEUTICAL DEVELOPMENT, INC.
To: GALDERMA LABORATORIES INC.
Reel/Frame 029703/0739 →
Assignment of Assignor's Interest
Jun 3, 2014
From: MALLARD, CLAIRE; BRZOKEWICZ, ALAIN
To: GALDERMA S.A.
Reel/Frame 033021/0430 →
Assignment of Assignor's Interest
Nov 5, 2014
From: GALDERMA LABORATORIES INC.
To: GALDERMA LABORATORIES, L.P.
Reel/Frame 034105/0937 →
Assignment of Assignor's Interest
Aug 8, 2016
From: GALDERMA LABORATORIES, L.P.
To: NESTLE SKIN HEALTH S.A.
Reel/Frame 039363/0320 →
Change of Name
Dec 31, 2020
From: NESTLÉ SKIN HEALTH S.A.
To: GALDERMA HOLDING SA
Reel/Frame 054899/0803 →
Assignment of Assignor's Interest
Apr 26, 2021
From: MANETTA, VINCENT; WATKINS, GARY R.
To: GALDERMA S.A.
Reel/Frame 056044/0935 →
Change of Name
Apr 26, 2021
From: NESTLÉ SKIN HEALTH SA
To: GALDERMA HOLDING SA
Reel/Frame 056045/0088 →
Asset Transfer Agreement
Apr 26, 2021
From: GALDERMA S.A.
To: NESTLÉ SKIN HEALTH SA
Reel/Frame 056048/0065 →
Change of Name
Oct 3, 2021
From: NESTLÉ SKIN HEALTH S.A.
To: GALDERMA HOLDING SA
Reel/Frame 057698/0356 →
Asset Transfer Agreement
Oct 3, 2021
From: GALDERMA S.A.
To: NESTLÉ SKIN HEALTH S.A.
Reel/Frame 057698/0295 →
Change of Name
Oct 3, 2021
From: NESTLÉ SKIN HEALTH S.A.
To: GALDERMA HOLDING SA
Reel/Frame 057680/0027 →